Second-line bevacizumab adds weeks in metastatic CRC: Commentary Journal Article

  

Author:	Lichtman, S. M.
Article Title:	Second-line bevacizumab adds weeks in metastatic CRC: Commentary
Keywords:	treatment response; overall survival; bevacizumab; fluorouracil; cancer combination chemotherapy; note; prospective study; colorectal cancer; progression free survival; irinotecan; statistical significance; folinic acid; observational study; oxaliplatin
Journal Title:	The Oncology Report
Issue:	JULY
ISSN:	1548-5323
Publisher:	International Medical News Group LLC
Date Published:	2012-01-01
Start Page:	10
Language:	English
PROVIDER:	scopus
DOI/URL:	http://www.scopus.com/inward/record.url?eid=2-s2.0-84864749115&partnerID=40&md5=a177ae372d02f7457b5bf548b585d67f
Notes:	--- - "Export Date: 4 September 2012" - "Source: Scopus"

https://synapse.mskcc.org/synapse/works/has_related_data_chk/33334